Viewing Study NCT01444820

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 4:12 AM
Ignite Modification Date: 2026-01-25 @ 7:20 PM
Study NCT ID: NCT01444820
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-12-04
First Post: 2011-09-29
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Hypofractionated, Dose Escalation Radiotherapy for High Risk Adenocarcinoma of the Prostate
Sponsor: Sir Mortimer B. Davis - Jewish General Hospital
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Prostate Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None radiation therapy View
None hypofractionation View
None hormonal therapy View
None high risk adenocarcinoma of the prostate View